Books > Professional & Technical > Technology: general issues > Nanotechnology
|
Buy Now
Nanoparticle-Based Drug Delivery in Cancer Treatment (Hardcover)
Loot Price: R6,174
Discovery Miles 61 740
|
|
Nanoparticle-Based Drug Delivery in Cancer Treatment (Hardcover)
Series: Nanotechnology for Drugs, Vaccines and Smart Delivery Systems
Expected to ship within 12 - 17 working days
|
The careful choice of nanoparticles as targets and in drug delivery
routes enhances therapeutic efficacy in cancer. Nanoparticle-Based
Drug Delivery in Cancer Treatment discusses nanotechnological
developments of interfering RNA-based nanoparticles, delivery
vehicles, and validated therapeutic RNAi-molecular target
interactions and explains the results of clinical and preclinical
trials. The book also gives strategies for universal methods of
constructing hybrid organic-inorganic nanomaterials that can be
widely applied in the biomedical field. Key Features: Reviews
recent advances of nanoparticle-mediated siRNA delivery systems and
their application in clinical trials for cancer therapy Focuses on
material platforms that establish NPs and both localized and
controlled gene silencing Emphasizes the most promising systems for
clinical application Surveys progress in nanoparticle-based
nanomedicine in cancer treatment Describes the most advanced of the
nonviral nanocarriers for delivery of oligonucleotides to malignant
blood cancer cells This book is a valuable resource for
researchers, professors, and students researching drug delivery,
gene carriers, cancer therapy, nanotechnology, and nanomaterials.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.